Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Predicting the future with stem cells.

Mohsin S, Wu JC, Sussman MA.

Circulation. 2014 Jan 14;129(2):136-8. doi: 10.1161/CIRCULATIONAHA.113.007045. Epub 2013 Nov 18. No abstract available.

2.

Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery".

D'Amario D, Leone AM, Iaconelli A, Luciani N, Gaudino M, Kannappan R, Manchi M, Severino A, Shin SH, Graziani F, Biasillo G, Macchione A, Smaldone C, Cellini C, Siracusano A, Ottaviani L, Massetti M, Goichberg P, Leri A, Anversa P, Crea F.

Circulation. 2014 Sep 23;130(13):e118-9. doi: 10.1161/CIRCULATIONAHA.114.010924. No abstract available. Erratum in: Circulation. 2015 Dec 1;132(22):e364.

PMID:
25245852
3.

Letter by Li and Shen regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery".

Li Y, Shen Z.

Circulation. 2014 Sep 23;130(13):e117. doi: 10.1161/CIRCULATIONAHA.113.008500. No abstract available.

PMID:
25245851
4.

Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.

D'Amario D, Leone AM, Iaconelli A, Luciani N, Gaudino M, Kannappan R, Manchi M, Severino A, Shin SH, Graziani F, Biasillo G, Macchione A, Smaldone C, De Maria GL, Cellini C, Siracusano A, Ottaviani L, Massetti M, Goichberg P, Leri A, Anversa P, Crea F.

Circulation. 2014 Jan 14;129(2):157-72. doi: 10.1161/CIRCULATIONAHA.113.006591. Epub 2013 Nov 18. Erratum in: Circulation. 2014 Aug 12;130(7):e65. Erratum in: Circulation. 2015 Dec 1;132(22):e363.

5.

Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.

Donndorf P, Kundt G, Kaminski A, Yerebakan C, Liebold A, Steinhoff G, Glass A.

J Thorac Cardiovasc Surg. 2011 Oct;142(4):911-20. doi: 10.1016/j.jtcvs.2010.12.013. Epub 2011 Mar 3. Review.

6.

[Morphological predictors of postoperative remodeling of the heart in patients with ischemic heart disease].

Shipulin VM, Kazakov VA, Krivoshchekov EB, Sukhodolo IV, Vaizov VKh, Lezhnev AA, Stasev AN, Aliab'ev FV.

Kardiologiia. 2007;47(8):57-9. Russian. No abstract available.

PMID:
18260914
7.

Implantation of CD133(+) stem cells in patients undergoing coronary bypass surgery.

Kopjar T, Biocina B, Cepulic BG, Milicic D.

Can J Cardiol. 2013 Nov;29(11):1533.e1. doi: 10.1016/j.cjca.2013.02.018. Epub 2013 Apr 26. No abstract available.

PMID:
23623327
9.

Endomyocardial biopsy foretells ventricular function recovery after coronary artery bypass grafting.

Moreno PL, Wender OB, Barra M, Pellanda LC, Rohde LE, Clausell N.

Arq Bras Cardiol. 2004 Nov;83(5):379-84; 373-8. Epub 2004 Nov 11. English, Portuguese.

10.

Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.

Benedetto U, Melina G, Capuano F, Comito C, Bianchini R, Simon C, Refice S, Angeloni E, Sinatra R.

J Cardiovasc Med (Hagerstown). 2008 Nov;9(11):1098-103. doi: 10.2459/JCM.0b013e32830a6daf.

PMID:
18852580
11.

Reply to letter from Kopjar et al.-the IMPACT-CABG Pilot Trial.

Noiseux N, Stevens LM, Prieto I, Salem R, Roy DC, Larose E, Mansour S.

Can J Cardiol. 2013 Nov;29(11):1533.e3. doi: 10.1016/j.cjca.2013.03.016. Epub 2013 May 29. No abstract available.

PMID:
23725864
12.

The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia.

Bhakta S, Greco NJ, Finney MR, Scheid PE, Hoffman RD, Joseph ME, Banks JJ, Laughlin MJ, Pompili VJ.

J Invasive Cardiol. 2006 May;18(5):212-8. Erratum in: J Invasive Cardiol. 2006 Jun;18(6):297. Scheid, Paul E [added].

PMID:
16670448
13.

Off-pump coronary artery bypass surgery is associated with fewer gene expression changes in the human myocardium in comparison with on-pump surgery.

Ghorbel MT, Cherif M, Mokhtari A, Bruno VD, Caputo M, Angelini GD.

Physiol Genomics. 2010 Jun;42(1):67-75. doi: 10.1152/physiolgenomics.00174.2009. Epub 2010 Mar 23.

14.

Coronary artery surgery for ischemic heart failure: risks, benefits, and the importance of assessment of myocardial viability.

Pitt M, Lewis ME, Bonser RS.

Prog Cardiovasc Dis. 2001 Mar-Apr;43(5):373-86. Review.

PMID:
11251125
15.

Left ventricular reconstruction benefits patients with ischemic cardiomyopathy and non-viable myocardium.

Ribeiro GA, da Costa CE, Lopes MM, Albuquerque AN, Antoniali F, Reinert GA, Franchini KG.

Eur J Cardiothorac Surg. 2006 Feb;29(2):196-201. Epub 2006 Jan 4.

PMID:
16388958
16.

Myocardial protection with high-dose beta-blockade in acute myocardial ischemia.

Geissler HJ, Davis KL, Laine GA, Ostrin EJ, Mehlhorn U, Hekmat K, Warters RD, Allen SJ.

Eur J Cardiothorac Surg. 2000 Jan;17(1):63-70.

PMID:
10735414
17.

Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues.

Wang W, McKinnie SM, Patel VB, Haddad G, Wang Z, Zhabyeyev P, Das SK, Basu R, McLean B, Kandalam V, Penninger JM, Kassiri Z, Vederas JC, Murray AG, Oudit GY.

J Am Heart Assoc. 2013 Jul 1;2(4):e000249. doi: 10.1161/JAHA.113.000249.

18.

Reperfusion adequacy and functional recovery.

Rohs TJ Jr, Benedict MB, Bolling SF.

Chest. 1997 Oct;112(4):1075-8.

PMID:
9377920
19.

Meta-analysis of coronary artery bypass graft surgery combined with stem cell transplantation in the treatment of ischemic heart diseases.

Qin SL, He CY, Xu JS, Lai XY, Liu SS, He WP.

Coron Artery Dis. 2015 Mar;26(2):170-5. doi: 10.1097/MCA.0000000000000193.

PMID:
25415856
20.

Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation.

Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz RJ, Boersma E, Dion RA.

Eur J Cardiothorac Surg. 2005 May;27(5):847-53.

PMID:
15848325

Supplemental Content

Support Center